Skip to main content

Advertisement

Log in

Management of Older Patients with Head and Neck Cancer: A Comprehensive Review

  • Review
  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

The projected increase in life expectancy over the next few decades is expected to result in a rise in age-related diseases, including cancer. Head and neck cancer (HNC) is a worldwide health problem with high rates of morbidity and mortality. In this report, we have critically reviewed the literature reporting the management of older patients with HNC. Older adults are more prone to complications and toxicities secondary to HNC treatment, especially those patients who are frail or have comorbidities. Thus, this population should be screened prior to treatment for such predispositions to maximize medical management of comorbidities. Chronologic age itself is not a reason for choosing less intensive treatment for older HNC patients. Whenever possible, also older patients should be treated according to the best standard of care, as nonstandard approaches may result in increased treatment failure rates and mortality. The treatment plan is best established by a multidisciplinary tumor board with shared decision-making with patients and family. Treatment modifications should be considered for those patients who have severe comorbidities, evidence of frailty (low performance status), or low performance status or those who refuse the recommendations of the tumor board.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Nations U-U. World population ageing 2019. UN; 2020.

    Book  Google Scholar 

  2. Jegu J, Binder-Foucard F, Borel C, Velten M. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol. 2013;49(1):9–14.

    Article  PubMed  Google Scholar 

  3. Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of “elderly.” Geriatr Gerontol Int. 2006;6(3):149–58.

    Article  Google Scholar 

  4. Chang CM, Yin WY, Wei CK, Wu CC, Su YC, Yu CH, et al. Adjusted age-adjusted Charlson Comorbidity Index Score as a risk measure of perioperative mortality before cancer surgery. PLoS ONE. 2016;11(2): e0148076.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Field AE, Robertson NA, Wang T, Havas A, Ideker T, Adams PD. DNA methylation clocks in aging: categories, causes, and consequences. Mol Cell. 2018;71(6):882–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R, et al. Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

    Article  CAS  PubMed  Google Scholar 

  8. Hubbard RE, Story DA. Patient frailty: the elephant in the operating room. Anaesthesia. 2014;69(Suppl 1):26–34.

    Article  PubMed  Google Scholar 

  9. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1):17–26.

    Article  PubMed  Google Scholar 

  10. Bortz WM 2nd. A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci. 2002;57(5):M283–8.

    Article  PubMed  Google Scholar 

  11. Robinson TN, Walston JD, Brummel NE, Deiner S, Brown CHT, Kennedy M, et al. Frailty for surgeons: review of a national institute on aging conference on frailty for specialists. J Am Coll Surg. 2015;221(6):1083–92.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Noor A, Gibb C, Boase S, Hodge JC, Krishnan S, Foreman A. Frailty in geriatric head and neck cancer: a contemporary review. Laryngoscope. 2018;128(12):E416–24.

    Article  PubMed  Google Scholar 

  13. Strandberg TE, Lindstrom L, Jyvakorpi S, Urtamo A, Pitkala KH, Kivimaki M. Phenotypic frailty and multimorbidity are independent 18-year mortality risk indicators in older men: the Helsinki Businessmen Study (HBS). Eur Geriatr Med. 2021;12(5):953–61.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sezgin D, O’Donovan M, Woo J, Bandeen-Roche K, Liotta G, Fairhall N, et al. Early identification of frailty: developing an international delphi consensus on pre-frailty. Arch Gerontol Geriatr. 2022;99: 104586.

    Article  PubMed  Google Scholar 

  15. Gordon EH, Hubbard RE. Differences in frailty in older men and women. Med J Aust. 2020;212(4):183–8.

    Article  PubMed  Google Scholar 

  16. O’Caoimh R, Sezgin D, O’Donovan MR, Molloy DW, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96–104.

    Article  PubMed  Google Scholar 

  17. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.

    Article  PubMed  Google Scholar 

  18. Nieman CL, Pitman KT, Tufaro AP, Eisele DW, Frick KD, Gourin CG. The effect of frailty on short-term outcomes after head and neck cancer surgery. Laryngoscope. 2018;128(1):102–10.

    Article  PubMed  Google Scholar 

  19. Subramaniam S, Aalberg JJ, Soriano RP, Divino CM. The 5-factor modified frailty index in the geriatric surgical population. Am Surg. 2021;87(9):1420–5.

    Article  PubMed  Google Scholar 

  20. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16(7):601–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.

    Article  CAS  PubMed  Google Scholar 

  22. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35(5):526–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166–72.

    Article  CAS  PubMed  Google Scholar 

  24. Pottel L, Lycke M, Boterberg T, Pottel H, Goethals L, Duprez F, et al. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life. Eur J Cancer Care (Engl). 2014;23(3):401–12.

    Article  CAS  PubMed  Google Scholar 

  25. Abt NB, Richmon JD, Koch WM, Eisele DW, Agrawal N. Assessment of the predictive value of the modified frailty index for Clavien-Dindo grade IV critical care complications in major head and neck cancer operations. JAMA Otolaryngol Head Neck Surg. 2016;142(7):658–64.

    Article  PubMed  Google Scholar 

  26. Clegg A, Bates C, Young J, Ryan R, Nichols L, Ann Teale E, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.

    Article  CAS  PubMed  Google Scholar 

  28. Wong YG, Hang JA, Francis-Coad J, Hill AM. Using comprehensive geriatric assessment for older adults undertaking a facility-based transition care program to evaluate functional outcomes: a feasibility study. BMC Geriatr. 2022;22(1):598.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Jones DM, Song X, Rockwood K. Operationalizing a frailty index from a standardized comprehensive geriatric assessment. J Am Geriatr Soc. 2004;52(11):1929–33.

    Article  PubMed  Google Scholar 

  30. Goldstein DP, Sklar MC, de Almeida JR, Gilbert R, Gullane P, Irish J, et al. Frailty as a predictor of outcomes in patients undergoing head and neck cancer surgery. Laryngoscope. 2020;130(5):E340–5.

    Article  PubMed  Google Scholar 

  31. Kunz V, Wichmann G, Wald T, Pirlich M, Zebralla V, Dietz A, et al. Frailty assessed with FRAIL scale and G8 questionnaire predicts severe postoperative complications in patients receiving major head and neck surgery. J Clin Med. 2022;11(16):1–11.

    Article  Google Scholar 

  32. Bras L, de Vries J, Festen S, Steenbakkers R, Langendijk JA, Witjes MJH, et al. Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: a prospective study. Oral Oncol. 2021;118: 105329.

    Article  CAS  PubMed  Google Scholar 

  33. Cleere EF, Davey MG, O’Neill JP. “Age is just a number”; frailty as a marker of peri-operative risk in head and neck surgery: systematic review and meta-analysis. Head Neck. 2022;44(8):1927–39.

    Article  PubMed  Google Scholar 

  34. Fu TS, Sklar M, Cohen M, de Almeida JR, Sawka AM, Alibhai SMH, et al. Is frailty associated with worse outcomes after head and neck surgery? A narrative review. Laryngoscope. 2020;130(6):1436–42.

    Article  PubMed  Google Scholar 

  35. Schimansky S, Lang S, Beynon R, Penfold C, Davies A, Waylen A, et al. Association between comorbidity and survival in head and neck cancer: results from Head and Neck 5000. Head Neck. 2019;41(4):1053–62.

    Article  PubMed  Google Scholar 

  36. Marengoni A, von Strauss E, Rizzuto D, Winblad B, Fratiglioni L. The impact of chronic multimorbidity and disability on functional decline and survival in elderly persons. A community-based, longitudinal study. J Intern Med. 2009;265(2):288–95.

    Article  CAS  PubMed  Google Scholar 

  37. Paleri V, Wight RG, Silver CE, Haigentz M Jr, Takes RP, Bradley PJ, et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol. 2010;46(10):712–9.

    Article  PubMed  Google Scholar 

  38. Derks W, de Leeuw JR, Hordijk GJ, Winnubst JA. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2005;262(1):21–6.

    Article  CAS  PubMed  Google Scholar 

  39. Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Multidisciplinary Larynx Cancer Working G, et al. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018;40(9):2060–9.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Trevisani LFM, Kulcsar IF, Leite AKN, Kulcsar MAV, Lima GAS, Dedivitis RA, et al. Nutritional and immunological parameters as prognostic factors in patients with advanced oral cancer. Braz J Otorhinolaryngol. 2022;88 Suppl 4(Suppl 4):S89–97.

    Article  PubMed  Google Scholar 

  41. Kowalski LP, Alcantara PS, Magrin J, Parise JO. A case-control study on complications and survival in elderly patients undergoing major head and neck surgery. Am J Surg. 1994;168(5):485–90.

    Article  CAS  PubMed  Google Scholar 

  42. de Bree R, Meerkerk CDA, Halmos GB, Makitie AA, Homma A, Rodrigo JP, et al. Measurement of sarcopenia in head and neck cancer patients and its association with frailty. Front Oncol. 2022;12: 884988.

    Article  PubMed  PubMed Central  Google Scholar 

  43. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129–33.

    Article  Google Scholar 

  44. Chargi N, Bril SI, Emmelot-Vonk MH, de Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhinolaryngol. 2019;276(5):1475–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Zwart AT, van der Hoorn A, van Ooijen PMA, Steenbakkers R, de Bock GH, Halmos GB. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019;10(5):1060–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Meerkerk CDA, Chargi N, de Jong PA, van den Bos F, de Bree R. Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients. Eur Arch Otorhinolaryngol. 2022;279(2):967–77.

    Article  CAS  PubMed  Google Scholar 

  47. Liu C, Wong PY, Chung YL, Chow SK, Cheung WH, Law SW, et al. Deciphering the "obesity paradox" in the elderly: a systematic review and meta-analysis of sarcopenic obesity. Obes Rev. 2022; pp. 1–15.

  48. Mendes ML, Mahl C, Carvalho AC, Santos VS, Tanajura DM, Martins-Filho PR. Frailty and risk of complications in head and neck oncologic surgery. Systematic review and dose-response meta-analysis. Med Oral Patol Oral Cir Bucal. 2021;26(5):e582–9.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Reizenstein JA, Bergstrom SN, Holmberg L, Linder A, Ekman S, Blomquist E, et al. Impact of age at diagnosis on prognosis and treatment in laryngeal cancer. Head Neck. 2010;32(8):1062–8.

    Article  PubMed  Google Scholar 

  50. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope. 2007;117(5):835–40.

    Article  PubMed  Google Scholar 

  51. Banh Chong T, Grosclaude P, Chabrillac E, Lozano S, Vergez S, Mourey L, et al. Outcomes of comprehensive geriatric assessment and surgical management in head and neck cancers of the elderly: an observational study. Eur Arch Otorhinolaryngol. 2023;280(1):329–38.

    Article  PubMed  Google Scholar 

  52. Hirano M, Mori K. Management of cancer in the elderly: therapeutic dilemmas. Otolaryngol Head Neck Surg. 1998;118(1):110–4.

    Article  CAS  PubMed  Google Scholar 

  53. Ortholan C, Lusinchi A, Italiano A, Bensadoun RJ, Auperin A, Poissonnet G, et al. Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more. Radiother Oncol. 2009;93(3):516–23.

    Article  PubMed  Google Scholar 

  54. Vilaseca I, Xavier Aviles-Jurado F, Lehrer E, Valduvieco I, Baste N, Delia Ramirez R, et al. CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy. Oral Oncol. 2022;134: 106088.

    Article  PubMed  Google Scholar 

  55. Rodrigo JP, Garcia-Velasco F, Ambrosch P, Vander Poorten V, Suarez C, Coca-Pelaz A, et al. Transoral laser microsurgery for glottic cancer in the elderly: efficacy and safety. Head Neck. 2019;41(6):1816–23.

    Article  PubMed  Google Scholar 

  56. Pignon JP, le Maitre A, Maillard E, Bourhis J, Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14.

    Article  PubMed  Google Scholar 

  57. Blanchard P, Lee AWM, Carmel A, Wai Tong N, Ma J, Chan ATC, et al. Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients. Clin Transl Radiat Oncol. 2022;32:59–68.

    Article  CAS  PubMed  Google Scholar 

  58. Amini A, Jones BL, McDermott JD, Serracino HS, Jimeno A, Raben D, et al. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base. Cancer. 2016;122(10):1533–43.

    Article  PubMed  Google Scholar 

  59. Iqbal MS, Dua D, Kelly C, Bossi P. Managing older patients with head and neck cancer: the non-surgical curative approach. J Geriatr Oncol. 2018;9(4):411–7.

    Article  PubMed  Google Scholar 

  60. Coca-Pelaz A, Halmos GB, Strojan P, de Bree R, Bossi P, Bradford CR, et al. The role of age in treatment-related adverse events in patients with head and neck cancer: a systematic review. Head Neck. 2019;41(7):2410–29.

    Article  PubMed  Google Scholar 

  61. Perri F, Ionna F, Pavone E, Longo F, Caponigro F. Treatment approaches in elderly patients with head and neck cancer. Anticancer Agents Med Chem. 2013;13(9):1383–90.

    Article  CAS  PubMed  Google Scholar 

  62. Porceddu SV, Haddad RI. Management of elderly patients with locoregionally confined head and neck cancer. Lancet Oncol. 2017;18(5):e274–83.

    Article  PubMed  Google Scholar 

  63. Szturz P, Bossi P, Vermorken JB. Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice. Curr Opin Otolaryngol Head Neck Surg. 2019;27(2):142–50.

    Article  PubMed  Google Scholar 

  64. Teymoortash A, Ferlito A, Halmos GB. Treatment in elderly patients with head and neck cancer: a challenging dilemma. HNO. 2016;64(4):217–20.

    Article  CAS  PubMed  Google Scholar 

  65. Lacas B, Bourhis J, Overgaard J, Zhang Q, Gregoire V, Nankivell M, et al. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. Lancet Oncol. 2017;18(9):1221–37.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Petit C, Lacas B, Pignon JP, Le QT, Gregoire V, Grau C, et al. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. Lancet Oncol. 2021;22(5):727–36.

    Article  CAS  PubMed  Google Scholar 

  67. Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 2010;11(1):21–8.

    Article  CAS  PubMed  Google Scholar 

  68. Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019;393(10166):40–50.

    Article  CAS  PubMed  Google Scholar 

  69. Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393(10166):51–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Eisbruch A. Radiotherapy: IMRT reduces xerostomia and potentially improves QoL. Nat Rev Clin Oncol. 2009;6(10):567–8.

    Article  PubMed  Google Scholar 

  71. Corry J, Peters LJ, Costa ID, Milner AD, Fawns H, Rischin D, et al. The ’QUAD SHOT’–a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol. 2005;77(2):137–42.

    Article  PubMed  Google Scholar 

  72. Ferrara R, Mezquita L, Auclin E, Chaput N, Besse B. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: does age really matter? Cancer Treat Rev. 2017;60:60–8.

    Article  CAS  PubMed  Google Scholar 

  73. Tao Y, Biau J, Sun XS, Sire C, Martin L, Alfonsi M, et al. Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015–01 PembroRad): a multicenter, randomized, phase II trial. Ann Oncol. 2023;34(1):101–10.

    Article  CAS  PubMed  Google Scholar 

  74. Yokota T, Hamauchi S, Shirasu H, Onozawa Y, Ogawa H, Onoe T, et al. How should we approach locally advanced squamous cell carcinoma of head and neck cancer patients ineligible for standard non-surgical treatment? Curr Oncol Rep. 2020;22(12):118.

    Article  CAS  PubMed  Google Scholar 

  75. Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, et al. Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol. 2021;39(9):956–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. List MA, Stracks J, Colangelo L, Butler P, Ganzenko N, Lundy D, et al. How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol. 2000;18(4):877–84.

    Article  CAS  PubMed  Google Scholar 

  77. Lopez Rodriguez-Arias F, Sanchez-Guillen L, Armananzas Ruiz LI, Diaz Lara C, Lacueva Gomez FJ, Balague Pons C, et al. A narrative review about prehabilitation in surgery: current situation and future perspectives. Cir Esp (Engl Ed). 2020;98(4):178–86.

    Article  PubMed  Google Scholar 

  78. Boright L, Doherty DJ, Wilson CM, Arena SK, Ramirez C. Development and feasibility of a prehabilitation protocol for patients diagnosed with head and neck cancer. Cureus. 2020;12(8): e9898.

    PubMed  PubMed Central  Google Scholar 

  79. Loewen I, Jeffery CC, Rieger J, Constantinescu G. Prehabilitation in head and neck cancer patients: a literature review. J Otolaryngol Head Neck Surg. 2021;50(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Lagier A, Mimouni-Benabu O, Baumstarck K, Boulogne O, Michel J, Benabu D, et al. The influence of age on postoperative complications after total laryngectomy or pharyngolaryngectomy. Eur J Surg Oncol. 2014;40(2):202–7.

    Article  CAS  PubMed  Google Scholar 

  81. Shi RJ, Xu CZ, Zhang CP, Jiang CY, Sun YY, Yan XJ, et al. Outcomes of laryngectomy in elderly patients with laryngeal carcinoma. Genet Mol Res. 2014;13(1):1955–63.

    Article  CAS  PubMed  Google Scholar 

  82. Boruk M, Chernobilsky B, Rosenfeld RM, Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg. 2005;131(7):605–9.

    Article  PubMed  Google Scholar 

  83. L’Esperance HE, Kallogjeri D, Yousaf S, Piccirillo JF, Rich JT. Prediction of mortality and morbidity in head and neck cancer patients 80 years of age and older undergoing surgery. Laryngoscope. 2018;128(4):871–7.

    Article  PubMed  Google Scholar 

  84. Lepera D, Leone F, Volpi L, Bignami M, Karligkiotis A, Lambertoni A, et al. Endoscopic endonasal approach for sinonasal and anterior skull base malignancies in the elderly. Head Neck. 2018;40(5):917–26.

    Article  PubMed  Google Scholar 

  85. Peters TT, Post SF, van Dijk BA, Roodenburg JL, van der Laan BF, Werker PM, et al. Free flap reconstruction for head and neck cancer can be safely performed in both young and elderly patients after careful patient selection. Eur Arch Otorhinolaryngol. 2015;272(10):2999–3005.

    Article  PubMed  Google Scholar 

  86. Peters TT, van Dijk BA, Roodenburg JL, van der Laan BF, Halmos GB. Relation between age, comorbidity, and complications in patients undergoing major surgery for head and neck cancer. Ann Surg Oncol. 2014;21(3):963–70.

    Article  PubMed  Google Scholar 

  87. Goh CS, Kok YO, Yong CP, Tan EW, Goh LG, Chew KY, et al. Outcome predictors in elderly head and neck free flap reconstruction: a retrospective study and systematic review of the current evidence. J Plast Reconstr Aesthet Surg. 2018;71(5):719–28.

    Article  PubMed  Google Scholar 

  88. Lacas B, Carmel A, Landais C, Wong SJ, Licitra L, Tobias JS, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group. Radiother Oncol. 2021;156:281–93.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Gebbia V, Di Marco P, Citarrella P. Systemic chemotherapy in elderly patients with locally advanced and/or inoperable squamous cell carcinoma of the head and neck: impact of anemia and role of recombinant human erythropoietin. Crit Rev Oncol Hematol. 2003;48(Suppl):S49-55.

    Article  PubMed  Google Scholar 

  90. Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol. 2004;22(2):262–8.

    Article  CAS  PubMed  Google Scholar 

  91. Sanabria A, Carvalho AL, Melo RL, Magrin J, Ikeda MK, Vartanian JG, et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck. 2008;30(2):170–7.

    Article  PubMed  Google Scholar 

  92. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–7.

    Article  CAS  PubMed  Google Scholar 

  93. Chen JH, Yen YC, Yang HC, Liu SH, Yuan SP, Wu LL, et al. Curative-intent aggressive treatment improves survival in elderly patients with locally advanced head and neck squamous cell carcinoma and high comorbidity index. Medicine (Baltimore). 2016;95(14): e3268.

    Article  PubMed  Google Scholar 

  94. Yang CC, Su YC, Lin YW, Huang CI, Lee CC. Differential impact of age on survival in head and neck cancer according to classic Cox regression and decision tree analysis. Clin Otolaryngol. 2019;44(3):244–53.

    Article  PubMed  Google Scholar 

  95. Lee DS, Ramirez RJ, Lee JJ, Valenzuela CV, Zevallos JP, Mazul AL, et al. Survival of young versus old patients with oral cavity squamous cell carcinoma: a meta-analysis. Laryngoscope. 2021;131(6):1310–9.

    Article  PubMed  Google Scholar 

  96. van Deudekom FJ, van der Velden LA, Zijl WH, Schimberg AS, Langeveld AP, Slingerland M, et al. Geriatric assessment and 1-year mortality in older patients with cancer in the head and neck region: A cohort study. Head Neck. 2019;41(8):2477–83.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck. 1998;20(3):216–23.

    Article  CAS  PubMed  Google Scholar 

  98. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol. 2007;14(4):1449–57.

    Article  PubMed  Google Scholar 

  99. Fancy T, Huang AT, Kass JI, Lamarre ED, Tassone P, Mantravadi AV, et al. Complications, mortality, and functional decline in patients 80 years or older undergoing major head and neck ablation and reconstruction. JAMA Otolaryngol Head Neck Surg. 2019;145(12):1150–7.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Derks W, de Leeuw RJ, Hordijk GJ, Winnubst JA. Quality of life in elderly patients with head and neck cancer one year after diagnosis. Head Neck. 2004;26(12):1045–52.

    Article  PubMed  Google Scholar 

  101. Derks W, Leeuw JR, Hordijk GJ, Winnubst JA. Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clin Otolaryngol. 2005;30(2):186–92.

    Article  CAS  PubMed  Google Scholar 

  102. Wells M, Cunningham M, Lang H, Swartzman S, Philp J, Taylor L, et al. Distress, concerns and unmet needs in survivors of head and neck cancer: a cross-sectional survey. Eur J Cancer Care (Engl). 2015;24(5):748–60.

    Article  CAS  PubMed  Google Scholar 

  103. Penedo FJ, Traeger L, Benedict C, Thomas G, Dahn JR, Krause MH, et al. Perceived social support as a predictor of disease-specific quality of life in head-and-neck cancer patients. J Support Oncol. 2012;10(3):119–23.

    Article  PubMed  Google Scholar 

  104. Richardson AE, Morton R, Broadbent E. Psychological support needs of patients with head and neck cancer and their caregivers: a qualitative study. Psychol Health. 2015;30(11):1288–305.

    Article  PubMed  Google Scholar 

  105. Bozec A, Majoufre C, De Boutray M, Gal J, Chamorey E, Roussel LM, et al. Oral and oropharyngeal cancer surgery with free-flap reconstruction in the elderly: factors associated with long-term quality of life, patient needs and concerns. A GETTEC cross-sectional study. Surg Oncol. 2020;35:81–8.

    Article  PubMed  Google Scholar 

  106. de Vries J, Bras L, Sidorenkov G, Festen S, Steenbakkers R, Langendijk JA, et al. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer. Oral Oncol. 2020;111: 105020.

    Article  PubMed  Google Scholar 

  107. de Vries J, Bras L, Sidorenkov G, Festen S, Steenbakkers R, Langendijk JA, et al. Association of deficits identified by geriatric assessment with deterioration of health-related quality of life in patients treated for head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2021;147(12):1089–99.

    Article  PubMed  Google Scholar 

  108. Lewis ET, Williamson M, Lewis LP, Ni Chroinin D, Dent E, Ticehurst M, et al. the feasibility of deriving the electronic frailty index from Australian General Practice Records. Clin Interv Aging. 2022;17:1589–98.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Funding

No funding or sponsorship was received for this study or publication of this article.

Author Contributions

Luiz Kowalski was responsible for concept and design of the study. Leandro Matos and Alvaro Sanabria did the literature review, wrote the manuscript, and performed the revision. All other co-authors (K. Thomas Robbins, Gyorgy Halmos, Primož Strojan, Wai Tong Ng, Robert Takes, Peter Angelos, Cesare Piazza, Remco de Bree, Ohad Ronen, Orlando Guntinas-Lichius, Avraham Eisbruch, Mark Zafereo, Antti Mäkitie, Ashok Shaha, Andres Coca-Pelaz, Alessandra Rinaldo, Nabil Saba, Oded Cohen, Fernando Lopez, Juan Rodrigo, Carl Silver, Timo Strandberg, Alfio Ferlito) wrote parts of the text according to each one's expertise and read, reviewed, and approved the final version of the manuscript.

Disclosures

All authors (Leandro Matos, Alvaro Sanabria, K. Thomas Robbins, Gyorgy Halmos, Primož Strojan, Wai Tong Ng, Robert Takes, Peter Angelos, Cesare Piazza, Remco de Bree, Ohad Ronen, Orlando Guntinas-Lichius, Avraham Eisbruch, Mark Zafereo, Antti Mäkitie, Ashok R. Shaha, Andres Coca-Pelaz, Alessandra Rinaldo, Nabil Saba, Oded Cohen, Fernando Lopez, Juan Rodrigo, Carl E. Silver, Timo Strandberg, Luiz Kowalski, Alfio Ferlito) have read and approved the final version of the manuscript and declare to not have any actual, potential, or apparent conflict of interest concerning with this study.

Compliance with Ethics Guidelines

This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luiz Paulo Kowalski.

Additional information

This article was written by members and invitees of the International Head and Neck Scientific Group (http://www.IHNSG.com).

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matos, L.L., Sanabria, A., Robbins, K.T. et al. Management of Older Patients with Head and Neck Cancer: A Comprehensive Review. Adv Ther 40, 1957–1974 (2023). https://doi.org/10.1007/s12325-023-02460-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12325-023-02460-x

Keywords

Navigation